Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.
about
A research agenda for helminth diseases of humans: intervention for control and eliminationA research agenda for helminth diseases of humans: towards control and eliminationResearch for new drugs for elimination of onchocerciasis in AfricaProspects and challenges of CRISPR/Cas genome editing for the study and control of neglected vector-borne nematode diseasesPotential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in AfricaGlutamate-gated chloride channels of Haemonchus contortus restore drug sensitivity to ivermectin resistant Caenorhabditis elegansThe transcriptional response of Caenorhabditis elegans to Ivermectin exposure identifies novel genes involved in the response to reduced food intakeDynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from CameroonHuman Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination ProgrammeDoes Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness?Metabolomics-based discovery of diagnostic biomarkers for onchocerciasis.A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infectionPhenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus.Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.A research agenda for helminth diseases of humans: modelling for control and elimination.A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasisUtilization of computer processed high definition video imaging for measuring motility of microscopic nematode stages on a quantitative scale: "The Worminator".Therapeutic efficacy and macrofilaricidal activity of doxycycline for the treatment of river blindnessDoxycycline Leads to Sterility and Enhanced Killing of Female Onchocerca volvulus Worms in an Area With Persistent Microfilaridermia After Repeated Ivermectin Treatment: A Randomized, Placebo-Controlled, Double-Blind TrialLong term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis.Heartworms, macrocyclic lactones, and the specter of resistance to prevention in the United States.Macrocycle peptides delineate locked-open inhibition mechanism for microorganism phosphoglycerate mutases.Genotypic analysis of β-tubulin in Onchocerca volvulus from communities and individuals showing poor parasitological response to ivermectin treatment.Progress and challenges in the discovery of macrofilaricidal drugs.Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse modelElucidating Gene-by-Environment Interactions Associated with Differential Susceptibility to Chemical Exposure
P2860
Q21562256-3FBFF3D4-C561-43D5-B06C-1DBC23669F53Q21562257-9415CA6A-385D-4B13-9127-36BF27833963Q28066402-A963A361-4F8E-4B0F-B779-8BA8B490F15EQ28074596-6C3073B4-A0C2-425E-A9DD-2F8BE862B756Q28468413-D101A0A5-3529-4B1A-A0F3-9891006D986CQ28479352-9ADD0A59-F5CD-4136-975C-3E5EF6F304DBQ28480640-599CC8C3-A217-4049-BC58-D325AAD49085Q28487094-AA94ABC1-EB55-4CA3-9678-7A0AADEB094BQ28546650-54F23B89-7EA7-449C-AC9A-C2256468E5B4Q28602538-FC4BB72E-4DCB-4D87-BE74-24F85E104DA2Q33721950-6BD11D6A-F5B6-4275-B8D9-CDA0A20888B4Q33812047-255A39DC-4F5B-463C-AE4F-F2C3E5528054Q33863602-5FF6A644-8D71-4B69-894D-3565C68FC94DQ34202166-E4809B1C-2154-4111-83E4-581551E16E5BQ34251353-85DB972A-08EC-42E2-806F-CD9B62156F27Q34416898-11237949-F9F6-41E1-95A8-6AAA6226F391Q34705652-15174E4A-7FDF-458C-896B-5D98344F1D5AQ35207455-FB0AB2D6-C285-49AA-805C-CBCEB6C52A49Q35898029-78EEFACD-63BA-463C-8C8A-869475B67AA0Q35953546-C557AFD8-3230-4DF3-A53E-98C2BE269908Q36123129-0A0836FA-4018-4863-BB12-AF5AEF3CB9BEQ36331476-7B088B41-6DB9-4812-ABB2-38E46AAEC421Q37390569-C21DABCF-D5E6-4196-8DCE-20058034638AQ37912232-6280ACBD-2086-45D5-972E-DD91FD48C6E0Q38977668-F3B96A4B-BE09-40E0-9BE6-7846B74AD73EQ56936216-740350F6-7861-443D-9B3F-74453F087AD5Q57554720-75ED9E37-F973-4906-8C21-078BBE586567
P2860
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.
@en
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.
@nl
type
label
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.
@en
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.
@nl
prefLabel
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.
@en
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.
@nl
P2093
P2860
P50
P356
P1476
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.
@en
P2093
James A Whitworth
Kwablah Awadzi
Mike Y Osei-Atweneboana
Richard C Collins
Roger K Prichard
Sébastien D S Pion
P2860
P304
16716-16721
P356
10.1073/PNAS.0906176106
P407
P577
2009-09-17T00:00:00Z